SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-22-007167
Filing Date
2022-02-14
Accepted
2022-02-14 06:08:28
Documents
1
Group Members
PONTIFAX 5 G.P. L.P.PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.TOMER KARIV

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO SCHEDULE 13G ea155545-13ga1nussba_pieris.htm SC 13G/A 142932
  Complete submission text file 0001213900-22-007167.txt   144418
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88917 | Film No.: 22624495
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G/A